U.S. RESEARCH ROUNDUP- Advance Auto Parts, Molina Healthcare, Walmart

Reuters08-16

Aug 16 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Advance Auto Parts, Molina Healthcare and Walmart on Friday.

HIGHLIGHTS

* Advance Auto Parts Inc : JP Morgan cuts target price to $55 from

$68

* Dare Bioscience Inc : Jonestrading raises target price to $13

from $5

* Molina Healthcare Inc : Mizuho raises target price to $382 from

$350

* Roper Technologies Inc : Jefferies raises target price to $635

from $625

* Walmart : RBC raises target price to $80 from $74

Following is a summary of research actions on U.S. companies reported by Reuters on Friday. Stock entries are in alphabetical order.

* Advance Auto Parts Inc : JP Morgan cuts target price to $55 from $68

* AGNC Investment Corp : RBC raises target price to $11 from $10

* Alibaba Group : JP Morgan raises target price to $108 from $100

* Amcor Plc : Baird raises target price to $11 from $10

* Amicus Therapeutics Inc : JP Morgan cuts target price to $16 from $17

* Applied Materials Inc : JP Morgan raises target price to $250 from $240

* Ardent Health Partners Inc : Mizuho raises target price to $21 from $20

* BJ's Wholesale Club Holdings Inc : JP Morgan raises PT to $76 from $74

* Brandywine Realty Trust : Evercore ISI raises target price to $5.50 from

$5

* Centene Corp : Mizuho raises target price to $77 from $76

* Cheniere Energy Inc : RBC raises target price to $201 from $198

* Dare Bioscience Inc : Jonestrading raises target price to $13 from $5

* Deere & Co : Daiwa Capital Markets cuts target price to $425 from $440

* Electra Battery Materials : Alliance Global Partners cuts PT to $1 from

$1.5

* ESS Tech Inc : Canaccord Genuity cuts target price to $1 from $1.25

* Globant SA : Piper Sandler raises target price to $240 from $238

* Mercury Systems Inc : Jefferies raises target price to $30 from $24

* Molina Healthcare Inc : Mizuho raises target price to $382 from $350

* Optimizerx Corp : RBC cuts target price to $14 from $17

* Perspective Therapeutics Inc : RBC cuts target price to $27 from $29

* Quipt Home Medical Corp : Canaccord Genuity cuts target price to $6

from $8

* Root Inc : KBW cuts target price to $82 from $88

* Roper Technologies Inc : Jefferies raises target price to $635 from $625

* Roper Technologies Inc : RBC raises target price to $675 from $674

* Sphere Entertainment Co : JP Morgan raises target price to $57 from $37

* Sphere Entertainment Co : JP Morgan raises to overweight from neutral

* UnitedHealth : Mizuho raises target price to $650 from $560

* Upwork Inc : Roth MKM cuts target price to $13 from $19

* Viracta Therapeutics : Leerink Partners cuts to market perform from

outperform

* Viracta Therapeutics : Leerink Partners cuts PT to $3 from $5

* $Vornado Realty Trust(VNO-N)$ : Evercore ISI raises target price to $32 from $31

* Walmart : D.A. Davidson raises target price to $85 from $75

* Walmart : HSBC raises target price to $85 from $81

* Walmart : Jefferies raises target price to $85 from $80

* Walmart : JP Morgan raises target price to $83 from $81

* Walmart : Piper Sandler raises target price to $83 from $81

* Walmart : RBC raises target price to $80 from $74

* Walmart : Roth MKM raises target price to $81 from $71

* Walmart : TD Cowen raises target price to $85 from $80

* Walmart : Telsey Advisory Group raises target price to $82 from $75

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment